Burke D J, Burke E, Parsaie F, Poirier V, Butler K, Thomas D, Taylor L, Maher T
Thermo Cardiosystems Inc. (now Thoratec Corp.), Woburn, Massachusetts, USA.
Artif Organs. 2001 May;25(5):380-5. doi: 10.1046/j.1525-1594.2001.06770.x.
Our group is developing the control and power transmission components required to implement a permanent and fully sealed left ventricular assist system (LVAS). Starting with the percutaneously powered HeartMate II blood pump, our development efforts are focused in the following areas: a complete redesign of the transcutaneous energy transmission system (TETS) to include a rectification network and autonomous voltage regulation within the secondary coil, a hermetically sealed electronics package containing a miniaturized implementation of the existing redundant drive and control electronics with several power-input options, an implanted rechargeable lithium ion battery pack capable of providing up to 1 h of untethered operation, implantable electrical connectors that allow components to be connected after placement in the body or to be replaced if needed, and a radio telemetry subsystem to transmit diagnostic information and to permit remote adjustment of selected parameters.
我们的团队正在开发实现永久性、全密封左心室辅助系统(LVAS)所需的控制和动力传输组件。从经皮供电的HeartMate II血泵开始,我们的研发工作集中在以下几个方面:对经皮能量传输系统(TETS)进行全面重新设计,使其在次级线圈内包含整流网络和自主电压调节功能;一个密封的电子封装,其中包含现有冗余驱动和控制电子设备的小型化实现,并具备多种电源输入选项;一个植入式可充电锂离子电池组,能够提供长达1小时的无束缚运行;植入式电连接器,允许组件在植入体内后进行连接,或在需要时进行更换;以及一个无线电遥测子系统,用于传输诊断信息并允许对选定参数进行远程调整。